Drugs / Colloidal pectin bismuth
last change Jul 2026 re-read 2 minutes ago

Colloidal pectin bismuth

also known as colloidal bismuth pectin
Developed for
Helicobacter pylori infectious disease
Investigated by
Nanjing First Hospital, Nanjing Medical University

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT06340334 Mar 2024 → Sep 2025 Helicobacter pylori infectious disease Nanjing First Hospital, Nanjing Medical University Completed No outcome recorded
Also used as a comparator or background therapy in 3 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 42 trials
Phase 4 NCT07122024 Comparator Feb 2024 → Aug 2025 overdue Helicobacter pylori infectious disease Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting No outcome recorded
Phase 4 NCT04209933 Comparator May → Aug 2020 Helicobacter pylori infectious disease, gastric cancer Xijing Hospital of Digestive Diseases Completed No outcome recorded
Phase not applicable1 trial
NCT06004401 Comparator Aug 2023 → Aug 2025 Shanghai Changzheng Hospital Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Colloidal pectin bismuth “Rabeprazole quadruple therapy for 14 days (R14 group): Rabeprazole sodium 10 mg + Amoxicillin 1 g + Clarithromycin 500 mg + Colloidal pectin bismuth 200 mg, bid, for 14 days.” NCT07122024
3

“Group B subjects received oral Tegoprazan 50 mg, bid + amoxicillin 1000 mg, bid + furazolidone 100 mg, bid + colloidal pectin bismuth 300 mg, bid.” NCT06340334

NCT06004401

NCT04209933

Known as colloidal bismuth pectin “Participants were randomly assigned in a 1:1 ratio to a 14-day course of either TA dual therapy (tegoprazan 50 mg twice daily and amoxicillin 1000 mg three times daily) or TBQ...” PMID 42457948 Jul 2026
Route Oral “Colloidal pectin bismuth capsules 200 mg,rabeprazole 10 mg, amoxicillin 1000mg, and clarithromycin 500 mg by mouth” NCT04209933